Skip to main content
. 2020 Aug 1;10(8):2570–2581.

Figure 3.

Figure 3

TGF-ß1 inhibition or HIF1A antibody treatment induces the expression of angiogenic factors and hydroxyproline. Several angiogenic factors amplified by EGLN2/3 and TGF-ß signaling were suppressed by incubation with the HIF1A antibody (A and B). On the other hand, the effects of TGF-ß were suppressed by LY364947 (A and B). Moreover, hydroxyproline concentrations in the culture supernatants were not suppressed by LY364947; however, they were suppressed by the HIF1A antibody (C).